Back
Day Range
$0.00
$0.00
52-Week Range
$0.00
$0.00
Volume
14,706
50D / 200D Avg
$0.00
/
$0.00
Prev Close
$0.00
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -143.7 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -128.3 | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | — | 0.2 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
No forward estimates available
Key Takeaways
Negative free cash flow of -894,320.0
PEG of 0.00 suggests growth is underpriced
Capital efficient — spends only 0.31% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)97.16%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net Margin-128.27%
Op. Margin-53.07%
Safety
Debt / Equity
N/A
Current Ratio0.31
Interest Coverage-4.34
Valuation
P/E Ratio
-143.74
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 97.16% | Revenue Growth (3Y) | 62.45% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.95M | Net Income (TTM) | -3.79M |
| ROE | N/A | ROA | -445.95% |
| Gross Margin | 25.05% | Operating Margin | -53.07% |
| Net Margin | -128.27% | Free Cash Flow (TTM) | -894,320.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.31 |
| Interest Coverage | -4.34 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -143.74 | P/B Ratio | N/A |
| P/S Ratio | 184.37 | PEG Ratio | 0.00 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 544.73M | Enterprise Value | 545.56M |
Income Statement
Annual, most recent first
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | 2.95M | 1.50M | 1.12M | 1.08M | 0.0 |
| Net Income | -3.79M | -28.54M | -2.79M | -1.12M | -2.10M |
| EPS (Diluted) | -1.19 | -18.84 | -0.03 | -0.67 | -348.71 |
| Gross Profit | 740,181.0 | 273,944.0 | 263,180.0 | 252,036.0 | 0.0 |
| Operating Income | -1.57M | -27.24M | -2.73M | -1.00M | -1.33M |
Balance Sheet
Annual, most recent first
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Total Assets | 849,816.0 | 2.64M | 627,162.0 | 2.90M | 1.56M |
| Total Liabilities | 2.19M | 2.25M | 922,286.0 | 561,823.0 | 275,156.0 |
| Shareholders' Equity | -1.34M | 391,017.0 | -295,124.0 | 2.34M | 1.28M |
| Total Debt | 966,395.0 | 1.03M | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 131,696.0 | 231,700.0 | 68,546.0 | 88,233.0 | 683,795.0 |
| Current Assets | 615,060.0 | 511,183.0 | 364,245.0 | 2.61M | 794,312.0 |
| Current Liabilities | 2.02M | 1.29M | 922,286.0 | 561,823.0 | 275,156.0 |